CEST Radiomics for Accurate Differentiation of True Tumour Progression from Treatment Effects in Brain Metastases Using Machine Learning
Motivation: Brain metastases are common and difficult to diagnose accurately post-stereotactic radiosurgery (SRS), particularly in distinguishing true tumor progression (TP) from radiation necrosis (RN) non-invasively. Goal(s): To develop a machine learning (ML) model using chemical exchange saturation transfer (CEST) imaging and MRI sequences to differentiate TP from RN. Approach: Radiomic features from APT, NOE, and asymmetry CEST images, along with FLAIR, T1, and T2 MRI sequences, were extracted to train ML models for TP and RN classification. Results: The Extra Trees model with APT and asymmetry-based MTR features achieved high accuracy (AUC=0.86), showing AI's potential to improve non-invasive diagnostics in clinical practice. Impact: These findings suggest that AI-driven analysis of combined CEST and MRI features could serve as an effective diagnostic tool in clinical practice, potentially improving patient management without the need for further invasive procedures.
Authors
- Dafna Sussman (ORCID: https://orcid.org/0000-0001-9977-3131)
- Arjun Sahgal (ORCID: https://orcid.org/0000-0001-7991-8970)
- Wilfred Lam (ORCID: https://orcid.org/0000-0002-9883-6142)
- Greg J. Stanisz (ORCID: https://orcid.org/0000-0002-9488-7612)
- Pejman Maralani (ORCID: https://orcid.org/0000-0001-9975-4379)
- Rachel Chan (ORCID: https://orcid.org/0000-0002-5820-1919)
- Hany Soliman (ORCID: https://orcid.org/0000-0003-2824-2100)
- Dylan Young (ORCID: https://orcid.org/0000-0001-6391-5791)
Publication Details
- Journal
- Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
- Published
- 2025-09-16
- DOI
- https://doi.org/10.58530/2025/0237
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00